Gamma Investing LLC Supernus Pharmaceuticals, Inc. Transaction History
Gamma Investing LLC
- $1.17 Trillion
- Q4 2024
A detailed history of Gamma Investing LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 1,053 shares of SUPN stock, worth $39,476. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,053
Previous 808
30.32%
Holding current value
$39,476
Previous $25.2 Million
51.14%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SUPN
# of Institutions
279Shares Held
60.6MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$390 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$230 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$191 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$108 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$98.7 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.01B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...